Yes, research supports exercising on GLP-1 medications — and the evidence suggests it is essential, not optional. Studies show GLP-1 users move measurably less after starting treatment, yet sustained physical activity is what protects muscle mass, bone density, and cardiovascular health. How active you stay may determine how durable your results are.

Key Takeaways

• A 2026 study presented at ENDO (the Endocrine Society meeting), using NIH All of Us and Fitbit data, found GLP-1 users dropped from 5,047 to 4,487 daily steps and from 28 to 22 minutes of moderate-to-vigorous activity per day — a decline worth deliberate countermeasures.
• A Health & Fitness Association report — an industry-body estimate based on population-level modeling — projected that pairing structured exercise with weight-loss medications could prevent approximately 50,000 cardiovascular events and $27 billion in U.S. medical costs over a decade.
• GLP-1 medications reduce appetite significantly, which can make it harder to fuel workouts adequately — intentional nutrition and activity tracking become more important, not less.
• Sustained physical activity supports muscle, bone, and cardiometabolic health during and after GLP-1 treatment, helping preserve the gains made while on medication.
• Tracking daily movement through a tool like Paceline's Health Score can help users on GLP-1s stay accountable during a period when the natural tendency is to move less.

What are GLP-1 medications, and why does exercise matter alongside them?

GLP-1 receptor agonists — medications such as semaglutide and tirzepatide, sold under brand names including Ozempic, Wegovy, and Mounjaro — are a class of drugs originally developed for type 2 diabetes management and now widely prescribed for weight loss. They work by mimicking a gut hormone that regulates appetite and blood sugar, helping people eat less and lose weight more consistently than most prior pharmacological options. Their rise has been significant: millions of Americans are currently on some form of GLP-1 therapy.

But weight loss achieved through appetite suppression alone carries a meaningful trade-off. When the body loses weight rapidly without sufficient physical activity, a substantial portion of that loss can come from lean muscle mass rather than fat alone. Sustained physical activity supports maintaining muscle, bone, and cardiometabolic health during and after GLP-1 treatment — and that distinction matters enormously for long-term health, mobility, and metabolic function.

Are people on GLP-1s actually exercising less?

The data here is striking and worth taking seriously. A 2026 study presented at ENDO, the Endocrine Society's annual meeting, used the NIH All of Us Research Program linked with participants' Fitbit data and found that adults with obesity who started a GLP-1 medication reduced their activity from 5,047 to 4,487 daily steps and from 28 to 22 minutes of moderate-to-vigorous activity per day. These results were presented at a conference rather than published in a peer-reviewed journal, and individual experiences vary — but with 753 people tracked via wearables, the signal merits attention. The likely explanation is multifactorial: reduced caloric intake can lower energy availability, nausea and other early side effects can discourage movement, and the psychological relief of seeing the scale drop may reduce the perceived urgency of working out.

This is one of the more counterintuitive findings in the current GLP-1 conversation. A medication designed to improve health outcomes appears, in practice, to coincide with a measurable reduction in one of the most important health behaviors we know of. Recognizing that pattern is the first step toward countering it.

What does the research say about combining exercise with GLP-1 treatment?

The case for pairing structured movement with GLP-1 therapy is not simply intuitive — it is supported by meaningful projections from health and fitness research. A Health & Fitness Association report — an industry-body estimate based on population-level modeling, and one that should be read with that context in mind — projected that combining structured exercise with weight-loss medications could prevent roughly 50,000 cardiovascular events and approximately $27 billion in U.S. medical costs over a decade. While such estimates carry inherent uncertainty, the underlying premise aligns with what exercise science has long established: physical activity substantially amplifies the cardiovascular and metabolic benefits that GLP-1 medications can initiate.

Exercise on GLP-1 therapy serves several overlapping functions. Resistance training in particular helps preserve and rebuild lean muscle mass during periods of caloric restriction. Aerobic activity supports heart health, insulin sensitivity, and mood regulation. And consistent daily movement — even walking — contributes to the metabolic adaptations that help sustain weight management after medication use ends or is reduced.

How should you think about nutrition and fueling workouts on a GLP-1?

One of the practical challenges of staying active on Ozempic or similar medications is that dramatically reduced appetite makes it easy to under-fuel. A person consuming significantly fewer calories than usual who then attempts moderate-to-vigorous exercise may find performance suffers, fatigue increases, and recovery slows. This is not a reason to avoid exercise — it is a reason to be deliberate about protein intake, meal timing, and overall nutritional adequacy.

Adequate protein is especially important during GLP-1 treatment. Protein supports muscle protein synthesis, which counteracts the muscle loss that can accompany rapid weight reduction. While specific dietary recommendations should come from a registered dietitian or healthcare provider familiar with your situation, the general principle is clear: eating less does not mean nutrition quality matters less. It means it matters more.

How can tracking help you stay active while on a GLP-1?

Given that the research points to a measurable drop in activity after starting GLP-1 treatment, structured accountability becomes a genuinely useful tool — not a motivational nicety. Knowing your daily step count, your weekly active minutes, and how your effort levels trend over time gives you concrete data to work with rather than vague impressions.

This is where a platform like Paceline offers meaningful support. The Paceline Score is a premium feature within the upcoming Paceline+ subscription that synthesizes your activity data into a single, trackable metric reflecting your overall movement and effort. For someone navigating the activity dip that frequently accompanies GLP-1 therapy, having a Health Score to monitor creates a feedback loop that encourages consistency even when motivation or energy is lower than usual.

Paceline will also offer Personalized Goals and Badges through its premium Paceline+ tier, which add structure and milestones to an exercise routine — particularly useful when progress feels less visible than it might during a period of active weight change. Exploring Paceline's Wellness Collection can also surface equipment and products from well-regarded brands that support an active lifestyle alongside medical treatment.

What is the bottom line on exercise and GLP-1 medications?

GLP-1 medications are a legitimate and effective tool for weight management, but they are not a substitute for physical activity — they are a context in which physical activity becomes even more important. The evidence is consistent: movement protects muscle, supports cardiovascular health, and helps lock in the metabolic improvements these drugs can initiate. The challenge is that the medications themselves appear to reduce the drive to move, making intentional, tracked, structured exercise a priority rather than an afterthought.

If you are currently on a GLP-1 medication or considering one, speak with your healthcare provider about how to integrate a sustainable exercise plan into your treatment. The goal is not just weight loss — it is durable, whole-body health, and exercise is a non-negotiable part of reaching it.

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your medication, diet, or exercise routine, particularly if you are currently using a GLP-1 medication.

Frequently Asked Questions

Is it safe to exercise while taking a GLP-1 medication like Ozempic or Wegovy?

For most people, exercise is not only safe but strongly recommended during GLP-1 treatment. That said, reduced caloric intake and potential side effects like nausea can affect energy levels, so it is important to consult your healthcare provider about the right type and intensity of activity for your specific situation.

Why do people on GLP-1s tend to move less after starting the medication?

A 2026 study presented at ENDO (Endocrine Society), using NIH All of Us and Fitbit data, found GLP-1 users dropped from 5,047 to 4,487 daily steps and from 28 to 22 minutes of moderate-to-vigorous activity per day. Reduced energy from lower caloric intake, early side effects, and decreased perceived urgency to exercise may all contribute to this pattern.

What type of exercise is most beneficial when using a GLP-1 for weight loss?

A combination of resistance training and aerobic activity is generally considered most beneficial. Resistance training helps preserve lean muscle mass during periods of caloric restriction, while aerobic exercise supports cardiovascular and metabolic health. Your healthcare provider or a certified fitness professional can help tailor a plan to your needs.

How does exercise affect long-term outcomes for people using weight-loss medications?

The evidence points in a clear direction. A Health & Fitness Association report — an industry-body projection based on population-level modeling — estimated that combining structured exercise with weight-loss medications could prevent roughly 50,000 cardiovascular events and $27 billion in U.S. medical costs over a decade, suggesting that physical activity substantially amplifies the long-term benefits of GLP-1 treatment.

How can I track whether I am staying active enough while on a GLP-1?

Monitoring daily steps, active minutes, and effort levels through a dedicated wellness platform can help. Paceline's Health Score, available through the Paceline+ subscription, synthesizes your activity data into a single trackable metric, making it easier to spot and correct activity dips during GLP-1 treatment.

Will stopping a GLP-1 medication reverse weight-loss results if I am not exercising?

Research consistently shows that weight regain is a significant risk when GLP-1 medications are discontinued without supporting lifestyle habits in place. Sustained physical activity is one of the most important factors in maintaining cardiometabolic improvements after medication use changes, which is why exercise should be built into the treatment plan from the start.